ReviewBreast cancer research and treatment2026

Topoisomerase I inhibitor antibody-drug conjugates in breast cancer: the relevance of the DNA damage response to resistance, response, and combination treatment strategies.

Dayle K Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.